Lataa...
Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy
Hypoxia/HIF-1α– and extracellular adenosine/A2 adenosine receptor–mediated immunosuppression protects tissues from collateral damage by antipathogen immune cells. However, this mechanism also protects cancerous tissues by inhibiting antitumor immune cells in hypoxic and extracellular adenosine–rich...
Tallennettuna:
| Julkaisussa: | J Clin Invest |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Clinical Investigation
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7598059/ https://ncbi.nlm.nih.gov/pubmed/32870821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI137554 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|